| Deep brain stimulation in early-stage Parkinson disease: Five-year outcomes ML Hacker, M Turchan, LE Heusinkveld, AD Currie, SH Millan, ... Neurology 95 (4), e393-e401, 2020 | 107 | 2020 |
| Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease ML Hacker, MR DeLong, M Turchan, LE Heusinkveld, JL Ostrem, ... Neurology 91 (5), e463-e471, 2018 | 74 | 2018 |
| Impact of tremor on patients with early stage Parkinson's disease LE Heusinkveld, ML Hacker, M Turchan, TL Davis, D Charles Frontiers in neurology 9, 628, 2018 | 57 | 2018 |
| Coenzyme Q protects Caenorhabditis elegans GABA neurons from calcium-dependent degeneration LR Earls, ML Hacker, JD Watson, DM Miller Proceedings of the National Academy of Sciences 107 (32), 14460-14465, 2010 | 48 | 2010 |
| Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease ML Hacker, J Tonascia, M Turchan, A Currie, L Heusinkveld, PE Konrad, ... Parkinsonism & related disorders 21 (10), 1177-1183, 2015 | 45 | 2015 |
| Subthalamic nucleus deep brain stimulation may reduce medication costs in early stage parkinson’s disease ML Hacker, AD Currie, AL Molinari, M Turchan, SM Millan, ... Journal of Parkinson's disease 6 (1), 125-131, 2016 | 31 | 2016 |
| A Salmonella typhimurium strain defective in uracil catabolism and β-alanine synthesis. TP West, DA Beck, EB Burnette, R Gant, GM Meyer, MF Santiago, ... Research Journal of Microbiology 6 (2), 162-167, 2008 | 26* | 2008 |
| BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson’s Disease DL Fischer, P Auinger, JL Goudreau, A Cole-Strauss, K Kieburtz, JJ Elm, ... Neurotherapeutics 17 (4), 1785-1795, 2020 | 13 | 2020 |
| Deep brain stimulation in early stage Parkinson's disease. D Charles, PE Konrad, TL Davis, JS Neimat, ML Hacker, SG Finder Parkinsonism & related disorders 21 (3), 347-348, 2014 | 13 | 2014 |
| A comparative evaluation of telehealth and direct assessment when screening for spasticity in residents of two long-term care facilities KA Harper, EC Butler, ML Hacker, A Naik, BR Eoff, FT Phibbs, DA Isaacs, ... Clinical Rehabilitation 35 (4), 589-594, 2021 | 12 | 2021 |
| Patient perspectives on deep brain stimulation clinical research in early stage Parkinson’s disease L Heusinkveld, M Hacker, M Turchan, M Bollig, C Tamargo, W Fisher, ... Journal of Parkinson's disease 7 (1), 89-94, 2017 | 12 | 2017 |
| Prevalence of spasticity in nursing home residents CE Gill, ML Hacker, J Meystedt, M Turchan, JF Schnelle, SF Simmons, ... Journal of the American Medical Directors Association 21 (8), 1157-1160, 2020 | 11 | 2020 |
| Recruitment and Retention in Clinical Trials of Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Past Experiences and Future Considerations K Grace Cannard, ML Hacker, A Molinari, LE Heusinkveld, AD Currie, ... Journal of Parkinson's disease 8 (3), 421-428, 2018 | 10 | 2018 |
| Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medication costs M Hacker, G Cannard, M Turchan, J Meystedt, T Davis, F Phibbs, ... Clinical Neurology and Neurosurgery 210, 106976, 2021 | 9 | 2021 |
| The prevalence of spasticity in veterans living in a long-term care facility M Turchan, TS Hudson, CE Gill, A Currie, AL Molinari, ML Hacker, ... Int J Neurol Neurother 3 (5), 2-5, 2017 | 7 | 2017 |
| Deep brain stimulation in early stage Parkinson's disease may reduce the relative risk of symptom worsening M Hacker, D Charles, S Finder Parkinsonism & related disorders 22, 112-113, 2016 | 7 | 2016 |
| Spasticity diagnosis and treatment in the United States-a priority for our aging population L Sayce, T Hudson, LE Heusinkveld, AD Currie, M Hacker, D Charles Int J Neurorehabilitation 3 (3), 2376-0281.1000216, 2016 | 7 | 2016 |
| Eleven-year outcomes of deep brain stimulation in early-stage Parkinson disease ML Hacker, JC Meystedt, M Turchan, KR Cannard, K Harper, R Fan, F Ye, ... Neuromodulation: Technology at the Neural Interface 26 (2), 451-458, 2023 | 6 | 2023 |
| BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early‐Stage Parkinson's Disease CE Sortwell, ML Hacker, DL Fischer, PE Konrad, TL Davis, JS Neimat, ... Neuromodulation: Technology at the Neural Interface, 2021 | 6 | 2021 |
| Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson’s Disease Is Not Associated with Increased Body Mass Index SH Millan, ML Hacker, M Turchan, AL Molinari, AD Currie, D Charles Parkinson’s Disease 2017, 2017 | 6 | 2017 |
David Charles, MDProfessor and Vice-Chair of NeurologyVerified email at vanderbilt.edu
